Identification and Validation of a Novel Multi-Omics Signature for Prognosis and Immunotherapy Response of Endometrial Carcinoma

Ling Ji , Xiaofeng Li, Qiu Wang, Jiantong Zheng, Xiuqing Liu; Abraham Jia.

  • Name: Ling Ji
  • Phone: +86-13714685518
  • Country: China
  • Received date: 28 February, 2022
  • Accepted date: 23 June, 2022
  • Published date: 30 June, 2022

Designation: Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, PR China

Citation: Ji L, Li X, Wang Q, Zheng J, Liu X, et al. (2022) Identification and Validation of a Novel Multi-Omics Signature for Prognosis and Immunotherapy Response of Endometrial Carcinoma. J Biomed Res Rev Vol: 5, Issu: 1. (28-38).

Copyright: © 2022 Ji L et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Fulltext Under Construction
Facebook
Twitter
LinkedIn